Opinion
Korea Joongang Daily on MSN2dOpinion
A wake-up call for our drug authorities
The drug is a novel gene therapy to treat knee OA. Kolon developed it at a cost of more than 200 billion won ($143 million) since 1999. After clinical trials in Korea and the United States, the drug ...
Anchor] Do you remember the so-called 'Invossa incident' that caused a stir in society five years ago?It was released as the ...
Even if Kolon Group Chairman Lee Woong-yeol and others were acquitted in the first trial, the victims of the Invossa incident ...
Brace for the onslaught of Chinese EVs and Trump’s tariff (KOR) Kolon Industries flaunts quadrupled earnings on year in second quarter ...